ArticleFrontiers in pediatrics2026
Association of individual and bundled evidence-based practices with adverse outcomes in very preterm infants: a multicenter retrospective study.
Article in Frontiers in pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Although evidence-based practices (EBPs) can improve outcomes in very preterm infants (VPIs), real-world implementation rates and evidence regarding their synergistic effects remain limited. This study, which is based on the Shenzhen Neonatal Data Network (SNDN), evaluated the current implementation status of EBPs and the impact of their synergistic effects on clinical outcomes. Methods: We conducted a retrospective study on 536 VPIs with a gestational age <32 weeks in 2024. These infants were categorized into a survival without major morbidity group and an adverse outcome group (severe complications/death), with differences in the implementation of EBPs evaluated between the two groups. Using the "all-or-none" approach, we further assessed four core EBPs: complete course of antenatal corticosteroids (ACS); antenatal magnesium sulfate (MgSO₄); maintenance of normothermia (36.5 °C-37.5 °C) within one hour after birth; and caffeine therapy. Multivariate logistic regression analysis was employed to explore the associations between EBP implementation and adverse outcomes. Results: Bundle implementation of four EBPs significantly reduced adverse outcomes in VPIs (aOR=0.44, 95% CI: 0.23-0.83). Independent protective factors included delivery at tertiary perinatal centers with RDS management capabilities (aOR=0.18, 95% CI: 0.04-0.86); and normothermia within the first hour after birth (aOR=0.58, 95% CI: 0.37-0.91). Gestational age stratified analysis revealed that the protective effect of the four EBPs bundle was most pronounced in infants <28 weeks (aOR=0.22, 95% CI: 0.06-0.78).Only 19.4% of VPIs received all four EBPs. Conclusions: Bundled implementation of EBPs significantly improves clinical outcomes in VPIs. However, suboptimal adherence-particularly for normothermia within the first hour after birth-necessitates targeted quality improvement initiatives. We can enhance quality and improve survival without major morbidity in VPIs by systematically improving the implementation rates of EBPs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.